Skip to main content

Rebecca Young

Biostatistician, Senior
Duke Clinical Research Institute
200 Morris Street, Durham, NC 27701

Current Appointments & Affiliations


Recent Publications


Association of Race and Ethnicity With High-Potency P2Y12 Inhibitors Prescription Among Patients With Acute MI Undergoing PCI: An Analysis From the CathPCI Registry.

Journal Article Circ Cardiovasc Interv · February 2026 BACKGROUND: Racial and ethnic disparities exist in postacute myocardial infarction (AMI) care. High-potency P2Y12 inhibitors use among patients with AMI who undergo percutaneous coronary intervention (PCI) carries a class I indication in the guidelines. Th ... Full text Link to item Cite

Association of Acute Kidney Injury Risk and Same-Day Discharge Practices After Percutaneous Coronary Intervention.

Journal Article J Am Heart Assoc · November 4, 2025 BACKGROUND: Same-day discharge (SDD) after percutaneous coronary intervention (PCI) may be altered when complications occur. We sought to determine whether risk of the most common complication, acute kidney injury (AKI), is associated with SDD in practice. ... Full text Link to item Cite

Vericiguat and Cardiovascular Outcomes in Heart Failure by Baseline Diabetes Status: Insights From the VICTORIA Trial.

Journal Article JACC Heart Fail · October 2024 BACKGROUND: Type 2 diabetes mellitus (T2DM) significantly worsens heart failure (HF) prognosis. OBJECTIVES: This study sought to investigate the impact of T2DM on outcomes in patients enrolled in VICTORIA and assess the efficacy of vericiguat in patients w ... Full text Link to item Cite
View All Publications